Article Details

Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025

Retrieved on: 2025-10-07 16:10:17

Tags for this article:

Click the tags to see associated articles and topics

Arbutus Announces Four Abstracts Accepted for Presentation at AASLD - The Liver Meeting® 2025. View article details on hiswai:

Excerpt

07, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company ...

Article found on: www.theglobeandmail.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo